OnKure Therapeutics (OKUR) Misses Q2 EPS by 114c

OnKure Therapeutics (NASDAQ: OKUR) reported Q2 EPS of ($1.14).

For earnings history and earnings-related data on OnKure Therapeutics (OKUR) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
• Citi reiterates Buy rating on Baidu with $166 price target, Opens 30 Day Upside Catalyst Watch